Electrolytes supplementation can decrease the risk of nephrotoxicity in patients with solid tumors undergoing chemotherapy with cisplatin

BACKGROUND: Cisplatin is an important drug in the treatment of various Cancers. However, this drug causes nephrotoxicity that is linked to electrolyte derangement. The aim of this study was to evaluate the effect of electrolyte supplementation in reducing kidney injury in patients receiving cisplati...

Descripción completa

Detalles Bibliográficos
Autores principales: Minzi, Omary M. S., Lyimo, Tatu E., Furia, Francis F., Marealle, Alphonce I., Kilonzi, Manase, Bwire, George M., Malichewe, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510289/
https://www.ncbi.nlm.nih.gov/pubmed/32967726
http://dx.doi.org/10.1186/s40360-020-00448-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510289/
https://www.ncbi.nlm.nih.gov/pubmed/32967726
http://dx.doi.org/10.1186/s40360-020-00448-9

Ejemplares similares